Codes / ICD10CM / C85.24

C85.24 Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb
  • C85.24

Summary

Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb, is a subtype of non-Hodgkin lymphoma (NHL) that originates in the mediastinum, specifically involving the thymus and lymph nodes of the axilla and upper limb. It is characterized by the abnormal growth of large B lymphocytes. This condition is part of the broader NHL category and typically presents with localized involvement in the chest and upper extremity regions.

Causes

The exact cause of mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb, is often unknown but involves genetic mutations in B lymphocytes. Factors such as viral infections or immune system dysregulation may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

  • Advanced age (more common in young adults)
  • Weakened immune system (e.g., immunosuppressive therapy)
  • Certain infections (e.g., Epstein-Barr virus)
  • Exposure to chemicals (e.g., pesticides, herbicides)
  • Family history of lymphoma
  • Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

  • Swollen lymph nodes in the chest (mediastinal mass) and axilla/upper limb
  • Persistent cough or chest pain
  • Shortness of breath
  • Fever, night sweats, or unexplained weight loss
  • Fatigue or weakness
  • Difficulty swallowing

Diagnosis

Diagnosis typically involves a combination of imaging studies (e.g., CT or PET scans) to identify lymph node involvement, followed by a biopsy of the affected tissue to confirm the presence of large B-cell lymphoma. Additional tests, such as blood work or bone marrow aspiration, may be performed to assess disease spread and overall health.

Treatment Options

Treatment may include chemotherapy, immunotherapy, or radiation therapy, depending on the extent of the disease and patient-specific factors. In some cases, stem cell transplantation or targeted therapies may be considered. Treatment plans are tailored to the individual and often involve a multidisciplinary approach.

Prognosis and Follow-Up

Prognosis varies based on factors like disease stage, response to treatment, and overall health. Regular follow-up appointments, including imaging and blood tests, are essential to monitor for recurrence or progression. Long-term surveillance is typically recommended.

Complications

Potential complications include infection due to weakened immunity, organ damage from tumor growth, or side effects from treatment (e.g., fatigue, nausea, or neuropathy). In advanced cases, the disease may spread to other parts of the body.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding known carcinogens, may support overall well-being. Preventive measures focus on reducing exposure to risk factors, such as limiting chemical exposure or managing immune system health.

When to Seek Professional Help

Seek medical attention if you experience persistent symptoms like swollen lymph nodes, unexplained weight loss, or breathing difficulties. Early evaluation is crucial for timely diagnosis and treatment.

Tips for Medical Coders

When coding C85.24, ensure documentation specifies the involvement of mediastinal (thymic) large B-cell lymphoma in the lymph nodes of the axilla and upper limb. Verify that the primary site (mediastinum/thymus) and secondary site (axilla/upper limb lymph nodes) are clearly documented to support accurate code assignment.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C85.24 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.